PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Clinical evidence
An alcoholic extract of S. dulcamara and the isolated active principle beta-solamarine showed tumor-inhibitory activity [PMID:5859731]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 2080514 (1990) — Spirosolane-containing Solanum species and induction of congenital craniofacial malformations. · Toxicon : official journal of the International Society on Toxinology
- 2.PMID: 37869734 (2023) — The genome sequence of bittersweet, Solanum dulcamara L. (Solanaceae). · Wellcome open research
- 3.PMID: 1599942 (1992) — Plant thermal hysteresis proteins. · Biochimica et biophysica acta
- 4.PMID: 38474041 (2024) — Genetic Loci of Plant Pathogenic Dickeya solani IPO 2222 Expressed in Contact with Weed-Host Bittersweet Nightshade (Solanum dulcamara L.) Plants. · International journal of molecular sciences
- 5.PMID: 30743455 (2010) — Natural Occurrence of Phytophthora infestans Causing Late Blight on Woody Nightshade (Solanum dulcamara) in New York.